WebGenelux Corporation is committed to developing safe and effective next-generation immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our goal is to ensure access to our … WebSep 25, 2024 · SAN DIEGO, Sept. 25, 2024 /PRNewswire/ -- Genelux Corporation, a privately-held clinical-stage immunotherapy company, today announced that it has entered into a convertible note and warrant ...
Genelux Corporation (GNLX) Stock Price, News, Quote & History
WebThere are 24.55 M shares outstanding in Genelux Corporation Registered Shs, which values the company at $659.22 M. Genelux Corporation Registered Shs Stock … WebContact Email [email protected]. Phone Number 8584830026. Genelux Corporation is a privately-held, clinical stage biopharmaceutical company that has developed a proprietary oncolytic virus based technology platform and a deep pipeline of products with broad applications for cancer detection and therapy. GL-ONC1 the company’s lead oncology ... long overcoat india wedding wear
Genelux Corporation - GNLX - Stock Price Today - Zacks
WebWhat we know about the Genelux Corporation IPO. Genelux Corporation filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq Capital Market under the ticker symbol GNLX. Not yet an official IPO, this is one of the first steps of taking a private company public. When is Genelux Corporation … WebJan 26, 2024 · All of the shares are being offered by Genelux. In addition, Genelux has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares … WebApr 10, 2024 · Balance Sheet. The company has $397,000 in cash and $26.09 million in debt, giving a net cash position of -$25.69 million or -$1.05 per share. Cash & Cash Equivalents. 397,000. Total Debt. 26.09M. Net Cash. -25.69M. Net Cash Per Share. hope falls series